4Yip HK, Sun CK, Chang LT,et al. Time course andprognostic value of plasma levels of N-terminal pro-brain natriuretic peptide in patients after ischemicstroke[ J]. Circ J,2006,70(4) :447-452.
5Nakagawa K, YamagucKi T, Seida M , et al. Plasmaconcentrations of brain natriuretic peptide in patientswith acute ischemic stroke [ J ]. Cerebrovasc Dis,2005,19(3) :157-164.
6Pearson TA,Mensah GA,Alexander RW,et al.Markers of inflammation and cardiovascular disease:application to clinical and public health practice:a statement for healthcare professionals from the Centers for Disease Control and Prevention and the Am Heart Association.Circulation,2003,107:499-511.
7Di Napoli M,Di Gianfilippo G,Solecito A,et al.C-reactive protein and outcome after first-ever ischemic stroke.Stroke,2000,31:238-239.
8Rost NS,Wolf PA,Kase CS,et al.Plasma concentration of Creactive protein and risk of ischemia stroke and transient ischemic attack:the Framingham study.Stroke,2001,32:2575-2579.
9Winbeck K,Poppert H,Etgen T,et al.Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke.Stroke,2002,33:2459-2464.
10Di Napoli M,Papa F,Bocola V.Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke.Stroke,2001,32:133-138.
10Omland T, de Lemos JA, Sabatine MS, et al. A sensitive cardiac troponin T assay in stable coronary artery disease [J]. N Engl J Med,2009,361(26) :2538-2547.
